Form 4: Recursion Pharmaceuticals CFO Reports Stock Transaction
Insider Transaction (Form 4)
Ben R Taylor, Chief Financial Officer of Recursion Pharmaceuticals, Inc., reported a transaction in 5,396 shares of common stock on September 15, 2026.
Summary
- Tax/exercise-price withholding: disposed of 5,396 Class A Common Stock at $3.41 ($18,400) on September 15, 2026; holds 1,071,462 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ben R Taylor — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Tax/exercise-price withholding | Class A Common Stock | 5,396 | $3 | $18.4K | 1,071,462 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Tax/exercise-price withholding (5,396 shares) |
Keywords
insider transaction, Form 4, RXRX, RECURSION PHARMACEUTICALS, INC., neutral, Ben R Taylor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.